IMMUNOTHERAPY OF MANTLE CELL LYMPHOMA (MCL), LYMPHOPLASMACYTOID LYMPHOMA (LPC) AND WALDENSTROMS MACROGLOBULINEMIA (WM), AND SMALL LYMPHOCYTIC LYMPHOMA (SLL) WITH RITUXIMAB (IDEC-C288) - PRELIMINARY-RESULTS OF AN ONGOING INTERNATIONAL MULTICENTER TRIAL

FORAN JM ROHATINER AZS CUNNINGHAM D POPESCU R SOLAICELIGNY P CAVALLI F COIFFIER B JOHNSON P GISSELBRECHT C HAIOUN C BESSELL E SWEETENHAM J RADFORD J BENZOHRA A LISTER TA

Jm. Foran et al., IMMUNOTHERAPY OF MANTLE CELL LYMPHOMA (MCL), LYMPHOPLASMACYTOID LYMPHOMA (LPC) AND WALDENSTROMS MACROGLOBULINEMIA (WM), AND SMALL LYMPHOCYTIC LYMPHOMA (SLL) WITH RITUXIMAB (IDEC-C288) - PRELIMINARY-RESULTS OF AN ONGOING INTERNATIONAL MULTICENTER TRIAL, British Journal of Haematology, 102(1), 1998, pp. 149-149

NO

Hematology

British Journal of Haematology → ACNP

00071048

102

1

1998

S

149 - 149

ISI

0007-1048(1998)102:1<149:IOMCL(>2.0.ZU;2-E